Clean Yield Group’s AbbVie ABBV Stock Holding History

Clean Yield Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$844K	Hold	3,880	–	–	0.24%	74
2025 Q4	$887K	Sell	3,880 -300	-7%	-$68.3K	0.25%	76
2025 Q3	$968K	Sell	4,180 -74	-2%	-$15.1K	0.27%	71
2025 Q2	$790K	Sell	4,254 -211	-5%	-$39.2K	0.24%	76
2025 Q1	$936K	Sell	4,465 -51	-1%	-$9.91K	0.3%	68
2024 Q4	$802K	Sell	4,516 -30	-0.7%	-$5.52K	0.26%	73
2024 Q3	$898K	Sell	4,546 -151	-3%	-$28.2K	0.28%	69
2024 Q2	$806K	Buy	4,697 +11	+0.2%	+$1.82K	0.3%	62
2024 Q1	$853K	Sell	4,686 -30	-0.6%	-$5.17K	0.33%	62
2023 Q4	$731K	Hold	4,716	–	–	0.31%	60
2023 Q3	$704K	Hold	4,716	–	–	0.31%	60
2023 Q2	$635K	Sell	4,716 -100	-2%	-$14.7K	0.26%	68
2023 Q1	$768K	Sell	4,816 -311	-6%	-$47.5K	0.33%	60
2022 Q4	$829K	Hold	5,127	–	–	0.36%	63
2022 Q3	$688K	Sell	5,127 -806	-14%	-$116K	0.32%	64
2022 Q2	$909K	Hold	5,933	–	–	0.38%	59
2022 Q1	$962K	Buy	5,933 +2,120	+56%	+$308K	0.34%	65
2021 Q4	$516K	Sell	3,813 -154	-4%	-$18.2K	0.16%	94
2021 Q3	$428K	Buy	3,967 +817	+26%	+$93.4K	0.14%	96
2021 Q2	$355K	Buy	3,150 +560	+22%	+$63.1K	0.12%	100
2021 Q1	$280K	Sell	2,590 -100	-4%	-$10.7K	0.11%	115
2020 Q4	$288K	Sell	2,690 -1,100	-29%	-$106K	0.1%	114
2020 Q3	$332K	Buy	3,790 +100	+3%	+$9.41K	0.13%	95
2020 Q2	$362K	Sell	3,690 -200	-5%	-$17.6K	0.16%	81
2020 Q1	$296K	Sell	3,890 -7,900	-67%	-$673K	0.14%	92
2019 Q4	$1.04M	Hold	11,790	–	–	0.33%	59
2019 Q3	$893K	Sell	11,790 -100	-0.8%	-$6.86K	0.29%	62
2019 Q2	$865K	Buy	11,890 +357	+3%	+$28.1K	0.31%	61
2019 Q1	$929K	Buy	11,533 +300	+3%	+$24.5K	0.38%	59
2018 Q4	$1.04M	Buy	11,233 +750	+7%	+$66K	0.45%	60
2018 Q3	$991K	Hold	10,483	–	–	0.39%	66
2018 Q2	$971K	Hold	10,483	–	–	0.4%	66
2018 Q1	$992K	Buy	10,483 +900	+9%	+$98.9K	0.42%	65
2017 Q4	$927K	Hold	9,583	–	–	0.37%	70
2017 Q3	$852K	Hold	9,583	–	–	0.35%	72
2017 Q2	$701K	Sell	9,583 -15	-0.2%	-$1.01K	0.29%	79
2017 Q1	$625K	Buy	9,598 +1,920	+25%	+$121K	0.26%	84
2016 Q4	$481K	Hold	7,678	–	–	0.22%	88
2016 Q3	$484K	Sell	7,678 -22	-0.3%	-$1.42K	0.21%	91
2016 Q2	$477K	Hold	7,700	–	–	0.2%	90
2016 Q1	$455K	Hold	7,700	–	–	0.2%	88
2015 Q4	$451K	Hold	7,700	–	–	0.22%	88
2015 Q3	$410K	Sell	7,700 -1,778	-19%	-$116K	0.19%	95
2015 Q2	$637K	Sell	9,478 -400	-4%	-$26.1K	0.29%	86
2015 Q1	$578K	Buy	9,878 +630	+7%	+$38.1K	0.25%	83
2014 Q4	$605K	Hold	9,248	–	–	0.27%	79
2014 Q3	$534K	Hold	9,248	–	–	0.26%	82
2014 Q2	$522K	Buy	9,248 +500	+6%	+$26.2K	0.26%	83
2014 Q1	$450K	Hold	8,748	–	–	0.23%	94
2013 Q4	$462K	Hold	8,748	–	–	0.25%	87
2013 Q3	$391K	Hold	8,748	–	–	0.21%	92
2013 Q2	$362K	Buy	+8,748	New	+$383K	0.21%	88

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clean Yield Group's ABBV Position: Q1 2026 in Review

Clean Yield Group held its AbbVie (ABBV) position steady in Q1 2026 at 3,880 shares worth $844K. The position accounts for 0.24% of the portfolio, ranked #74.

Clean Yield Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.04M in Q4 2019. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Clean Yield Group held 3,880 shares of AbbVie worth $844K as of Q1 2026.
Clean Yield Group left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.24% of Clean Yield Group's portfolio in Q1 2026, its #74 holding.
Clean Yield Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Clean Yield Group's AbbVie position peaked at $1.04M in Q4 2019.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Clean Yield Group's 13F filing for Q1 2026, filed 14 Apr 2026.